-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 V7f30AWP6gRo+1K3csNILsgutJp5J4flQA903JOrypyp0dB/oTuYoF3Raa1IAtpm
 q6LMfJ/7FHzSnPoKmw5DWw==

<SEC-DOCUMENT>0001069306-98-000004.txt : 19980907
<SEC-HEADER>0001069306-98-000004.hdr.sgml : 19980907
ACCESSION NUMBER:		0001069306-98-000004
CONFORMED SUBMISSION TYPE:	SC 13D
PUBLIC DOCUMENT COUNT:		1
FILED AS OF DATE:		19980904
SROS:			NONE

SUBJECT COMPANY:	

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BIOMERICA INC
		CENTRAL INDEX KEY:			0000073290
		STANDARD INDUSTRIAL CLASSIFICATION:	DENTAL EQUIPMENT & SUPPLIES [3843]
		IRS NUMBER:				952645573
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0531

	FILING VALUES:
		FORM TYPE:		SC 13D
		SEC ACT:		
		SEC FILE NUMBER:	005-47729
		FILM NUMBER:		98704789

	BUSINESS ADDRESS:	
		STREET 1:		1533 MONROVIA AVENUE
		CITY:			NEWPORT BEACH
		STATE:			CA
		ZIP:			92663
		BUSINESS PHONE:		714-645-2111

	MAIL ADDRESS:	
		STREET 1:		1533 MONROVIA AVENUE
		CITY:			NEWPORT BEACH
		STATE:			CA
		ZIP:			92663

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NMS PHARMACEUTICALS INC
		DATE OF NAME CHANGE:	19871130

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NUCLEAR MEDICAL SYSTEMS INC
		DATE OF NAME CHANGE:	19830216

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	NUCLEAR INSTRUMENTS INC
		DATE OF NAME CHANGE:	19720508

FILED BY:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MOORE JANET
		CENTRAL INDEX KEY:			0001069306
		STANDARD INDUSTRIAL CLASSIFICATION:	 []

	FILING VALUES:
		FORM TYPE:		SC 13D

	BUSINESS ADDRESS:	
		STREET 1:		1533 MUNROVIA AVE
		CITY:			NEWPORT BEACH
		STATE:			CA
		ZIP:			92663
		BUSINESS PHONE:		9496452111

	MAIL ADDRESS:	
		STREET 1:		1533 MUNROVIA AVE
		CITY:			NEWPORT BEACH
		STATE:			CA
		ZIP:			92663
</SEC-HEADER>
<DOCUMENT>
<TYPE>SC 13D
<SEQUENCE>1
<TEXT>

- ------------------------------------------------------------------------------

                       SECURITIES AND EXCHANGE COMMISSION
                       ----------------------------------


                             WASHINGTON, D.C. 20549
                             -----------------------
                                 -------------

                                  SCHEDULE 13D
                                  ------------
                        UNDER THE SECURITIES ACT OF 1934
                        --------------------------------


                                BIOMERICA, INC.
                                ---------------
                                (Name of Issuer)
                                ----------------





                          $.08 Par Value Common Stock
                          ---------------------------
                         (Title of Class of Securities)



                                  09061H 30 7
                                  -----------
                                 (CUSIP Number)

          Janet Moore, 1533 Monrovia Avenue, Newport Beach, California 92663
          ------------------------------------------------------------------
  (Name, Address, Telephone Number of Person Authorized to Receive Notice and
                                Communications)



                                          July 2, 1998
                          ----------------------------
            (Date of Event Which Requires Filing of this Statement)



If the filing person has previously filed a statement on Schedule 13G to report
the acquisition that is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(b)(4)(i)(A) or (B), check the following box [ ].

1.   Names of Reporting Persons S.S. or I.R.S. Identification Nos. of Above
Persons

     Janet Moore

2.   Check the Appropriate Box if a Member of a Group (See Instructions)

     (a)  [  ]
     (b)  [  ]

3.   SEC Use Only

4.   Source of Funds (See Instructions)

<PAGE>
     Janet Moore                        OO

5.   Check if Disclosure of Legal Proceedings in Required Pursuant to Items 2(d)
or 2(e)
       -----------------------------------------------------------------------

6.   Citizenship or Place of Organization

     Janet Moore                        United States

7.   Number of Shares Beneficially Owned by Each Reporting Person With Sole
Voting Power

     Janet Moore                        465,670

8.   Shared Voting Power

     Janet Moore                        0

9.   Sole Dispositive Power

     Janet Moore                        465,670

10.  Shared Dispositive Power

     Janet Moore                        0

11.  Aggregate Amount Beneficially Owned by Each Reporting Person

     See Item 9, above.

12   Check if the Aggregate Amount in Row 11 Excludes Certain Shares (See
Instructions)

13.  Percent of Class Represented by Amount in Row 11

     Janet Moore                        11.7%

14.  Type of Reporting Person (See Instructions)

     Janet Moore                        IN

Item 1.   Security and Issuer.
          -------------------
<PAGE>
          The statement relates to the $.08 par value common stock of Biomerica,
Inc. (the "Registrant"), a Delaware corporation.

Item 2.   Identity and Background.
          -----------------------

          Janet Moore
          1533 Monrovia Avenue
          Newport Beach, California 92663


          The principal occupation of Janet Moore is controller of Biomerica,
Inc.  ("BMRA"), the Registrant.

Item 3.   Source and Amount of Funds or Other Consideration.
          -------------------------------------------------

     Janet Moore                        OO*

* Shares acquired through distribution of the estate of Joseph Irani.

Item 4.   Purpose of Transaction.
          ----------------------

          On April 28, 1997, Mr. Joseph Irani, Chairman of the Board, President
and Chief Financial Officer of Biomerica died of natural causes.  Pursuant to
the terms of his will, 387,010 shares of common stock were distributed to Janet
Moore, his wife and Director and controller of Biomerica, giving Ms. Moore
465,670 directly owned shares of Biomerica.

Item 5.   Interest in Securities of the Issuer.
          ------------------------------------

          Janet Moore                        11.50%

Item 6.   Contracts, Arrangements, Understandings or Relationships With Respect
          ---------------------------------------------------------------------

          to Securities of the Issuer.
          ---------------------------

          See Item 4, above.

Item 7.   Material to be Filed as Exhibits.
          --------------------------------

          None
<PAGE>



After reasonable inquiry and to the best or our knowledge and belief, we certify
that the information set forth in this statement is true, complete and correct.

Dated: September 3, 1998            /s/ Janet Moore
                                   ----------------

</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
